Loss of Rb overrides the requirement for ERK activity for cell proliferation

Journal of Cell Science

Volumn 115, Issue 23, 2002, Pages 4607-4616

  D'Abaco, Giovanna M ^a   Hooper, Steven ^a   Peterson, Hugh ^a   Marshall, Christopher J ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

ERK; MAP kinase; Ras; Retinoblastoma

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DOWNSTREAM PROCESSING; EMBRYO; ENZYME ACTIVITY; FIBROBLAST; GENETIC ANALYSIS; MITOGENESIS; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PHASE TRANSITION; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN FUNCTION; RETINOBLASTOMA; REVIEW; SIGNAL TRANSDUCTION; TUMOR CELL LINE; WILD TYPE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BUTADIENES; CELL DIVISION; CELLS, CULTURED; CHROMONES; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASES; CYCLINS; GENE DELETION; GENE EXPRESSION REGULATION; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; MORPHOLINES; NITRILES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS; RETINOBLASTOMA PROTEIN; TIME FACTORS; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0036901897     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.00161     Document Type: Review

References (58)

1. Aktas, H., Cai, H. and Cooper, G. M. (1997). Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1. Mol. Cell. Biol. 17, 3850-3857.
2. Albanese, C., Johnson, J., Watanabe, G., Eklund, N., Vu, D., Arnold, A. and Pestell, R. G. (1995). Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem. 270, 23589-23597.
3. Alessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T. and Saltiel, A. R. (1995). PD 098059 is a specific inhibitor of the activation of mitogen- activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270, 27489-27494.
4. Bos, J. L. (1989). ras oncogenes in human cancer: a review. Cancer Res. 49, 4682-4689.
5. Cai, H., Szeberenyi, J. and Cooper, G. M. (1990). Effect of a dominant inhibitory Ha-ras mutation on mitogenic signal transduction in NIH 3T3 cells. Mol. Cell. Biol. 10, 5314-5323.
6. Cheng, M., Sexl, V., Sherr, C. J. and Roussel, M. F. (1998). Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1). Proc. Natl. Acad. Sci. USA 95, 1091-1096.
7. Cheng, M., Olivier, P., Diehl, J. A., Fero, M., Roussel, M. F, Roberts, J. M. and Sherr, C. J. (1999). The p21 (Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 18, 1571-1583.
8. D'Abaco, G. M. and Olson, M. F. (2000). Mouse embryo fibroblasts: a genetic model system for studying Rho- and Ras-dependent cell cycle progression. Methods Enzymol. 325, 415-425.
9. Davies, S. P., Reddy, H., Caivano, M. and Cohen, P. (2000). Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351, 95-105.
10. Dickson, B. and Hafen, E. (1994). Genetics of signal transduction in invertebrates. Curr. Opin. Genet. Dev. 4, 64-70.
11. Diehl, J. A., Zindy, F. and Sherr, C. J. (1997). Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev. 11, 957-972.
12. Diehl, J. A., Cheng, M., Roussel, M. F. and Sherr, C. J. (1998). Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 12, 3499-3511.
13. Dobrowolski, S., Harter, M. and Stacey, D. W. (1994). Cellular ras activity is required for passage through multiple points of the G0/G1 phase in BALB/c 3T3 cells. Mol. Cell Biol. 14, 5441-5449.
14. Dudley, D. T., Pang, L., Decker, S. J., Bridges, A. J. and Saltiel, A. R. (1995). A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad Sci. USA 92, 7686-7689.
15. Favata, M. F., Horiuchi, K. Y., Manos, E. J., Daulerio, A. J., Stradley, D. A., Feeser, W. S., van Dyk, D. E., Pitts, W. J., Earl, R. A., Hobbs, F. et al. (1998). Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273, 18623-18632.
16. Feig, L. A. and Cooper, G. M. (1988). Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP. Mol. Cell. Biol. 8, 3235-3243.
17. Filmus, J., Robles, A. I., Shi, W., Wong, M. J., Colombo, L. L. and Conti, C. J. (1994). Induction of cyclin D1 overexpression by activated ras. Oncogene 9, 3627-3633.
18. Furth, M. E., Davis, L. J., Fleurdelys, B. and Scolnick, E. M. (1982). Monoclonal antibodies to the p21 products of the transforming gene of Harvey murine sarcoma virus and of the cellular ras gene family. J. Virol. 43, 294-304.
19. Gille, H. and Downward, J. (1999). Multiple ras effector pathways contribute to G(1) cell cycle progression. J. Biol. Chem. 274, 22033-22040.
20. Henry, D. O., Moskalenko, S. A., Kaur, K. J., Fu, M., Pestell, R. G., Camonis, J. H. and White, M. A. (2000). Ral GTPases contribute to regulation of cyclin D1 through activation of NF-kappaB. Mol. Cell. Biol. 20, 8084-8092.
21. Herrera, R. E., Sah, V. P., Williams, B. O., Makela, T. P., Weinberg, R. A. and Jacks, T. (1996). Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in Rb-deficient fibroblasts. Mol. Cell. Biol. 16, 2402-2407.
22. Hitomi, M. and Stacey, D. W. (2001). Ras-dependent cell cycle commitment during G2 phase. FEBS Lett. 490, 123-131.
23. Horowitz, J. M., Park, S. H., Bogenmann, E., Cheng, J. C., Yandell, D. W., Kaye, F. J., Minna, J. D., Dryja, T. P. and Weinberg, R. A. (1990). Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. Proc. Natl. Acad. Sci. USA 87, 2775-2779.
24. Jones, S. M. and Kazlauskas, A. (2001). Growth-factor-dependent mitogenesis requires two distinct phases of signalling. Nat. Cell Biol. 3, 165-172.
25. Jones, S. M., Klinghoffer, R., Prestwich, G. D., Toker, A. and Kazlauskas, A. (1999). PDGF induces an early and a late wave of PI 3-kinase activity, and only the late wave is required for progression through G1. Curr. Biol. 9, 512-521.
26. Kamakura, S., Moriguchi, T. and Nishida, E. (1999). Activation of the protein kinase ERK5/BMK1 by receptor tyrosine kinases. Identification and characterization of a signaling pathway to the nucleus. J. Biol. Chem. 274, 26563-26571.
27. Kashii, T., Mizushima, Y., Monno, S., Nakagawa, K. and Kobayashi, M. (1994). Gene analysis of K-, H-ras, p53, and retinoblastoma susceptibility genes in human lung cancer cell lines by the polymerase chain reaction/single-strand conformation polymorphism method. J. Cancer Res. Clin. Oncol. 120, 143-148.
28. Kato, Y., Tapping, R. I., Huang, S., Watson, M. H., Ulevitch, R. J. and Lee, J. D. (1998). Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor. Nature 395, 713-716.
29. Kelley, G. G., Reks, S. E., Ondrako, J. M. and Smrcka, A. V. (2001). Phospholipase C(epsilon): a novel Ras effector. EMBO J. 20, 743-754.
30. Kerkhoff, E. and Rapp, U. R. (1997). Induction of cell proliferation in quiescent NIH 3T3 cells by oncogenic c-Raf-1. Mol. Cell. Biol. 17, 2576-2586.
31. Kodaki, T., Woscholski, R., Hallberg, B., Rodriguez-Viciana, P., Downward, J. and Parker, P. J. (1994). The activation of phosphatidylinositol 3-kinase by Ras. Curr Biol. 4, 798-806.
32. Lavoie, J. N., L'Allemain, G., Brunet, A., Muller, R. and Pouyssegur, J. (1996). Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J. Biol. Chem. 271, 20608-20616.
33. Lee, K. Y., Ladha, M. H., McMahon, C. and Ewen, M. E. (1999). The retinoblastoma protein is linked to the activation of Ras. Mol. Cell. Biol. 19, 7724-7732.
34. Leevers, S. J. and Marshall, C. J. (1992). Activation of extracellular signal-regulated kinase, ERK2, by p21ras oncoprotein. EMBO J. 11, 569-574.
35. Liu, J. J., Chao, J. R., Jiang, M. C., Ng, S. Y., Yen, J. J. and Yang-Yen, H. F. (1995). Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells. Mol. Cell. Biol. 15, 3654-3663.
36. Lopez, I., Mak, E. C., Ding, J., Hamm, H. E. and Lomasney, J. W. (2001). A novel bifunctional phospholipase c that is regulated by Galpha 12 and stimulates the Ras/mitogen-activated protein kinase pathway. J. Biol. Chem. 276, 2758-2765.
37. Lukas, J., Bartkova, J., Rohde, M., Strauss, M. and Bartek, J. (1995). Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol. Cell. Biol. 15, 2600-2611,
38. Malek, N. P., Sundberg, H., McGrew, S., Nakayama, K., Kyriakidis, T. R. and Roberts, J. M. (2001). A mouse knock-in model exposes sequential proteolytic pathways that regulate p27Kip1 in G1 and S phase. Nature 413, 323-327.
39. Marshall, C. J. (1995). Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80, 179-185.
40. Marshall, C. J. (1996). Ras effectors. Curr. Opin. Cell Biol. 8, 197-204.
41. Mittnacht, S. (1998). Control of pRB phosphorylation. Curr. Opin. Genet. Dev. 8, 21-27.
42. Mittnacht, S., Paterson, H., Olson, M. F. and Marshall, C. J. (1997). Ras signalling is required for inactivation of the tumour suppressor pRb cell-cycle control protein. Curr. Biol. 7, 219-221.
43. Muise-Helmericks, R. C., Grimes, H. L., Bellacosa, A., Malstrom, S. E., Tsichlis, P. N. and Rosen, N. (1998). Cyclin D expression is controlled post-transcriptionally via a phosphatidylinositol 3-kinase/Akt-dependent pathway. J. Biol. Chem. 273, 29864-29872.
44. Mulcahy, L. S., Smith, M. R. and Stacey, D. W. (1985). Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells. Nature 313, 241-243.
45. Peeper, D. S., Upton, T. M., Ladha, M. H., Neuman, E., Zalvide, J., Bernards, R., DeCaprio, J. A. and Ewen, M. E. (1997). Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein. Nature 386, 177-181.
46. Rodriguez-Viciana, P., Warne, P. H., Dhand, R., Vanhaesebroeck, B., Gout, I, Fry, M. J., Waterfield, M. D. and Downward, J. (1994). Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 370, 527-532.
47. Rodriguez-Viciana, P., Warne, P. H., Vanhaesebroeck, B., Waterfield, M. D. and Downward, J. (1996). Activation of phosphoinositide 3-kinase by interaction with Ras and by point mutation. EMBO J. 15, 2442-2451.
48. Rodriguez-Viciana, F., Warne, P. H., Khwaja, A., Marte, B. M., Pappin, D., Das, F., Waterfield, M. D., Ridley, A. and Downward, J. (1997). Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell 89, 457-467.
49. Sherr, C. J. (1996). Cancer cell cycles. Science 274, 1672-1677.
50. Sherr, C. J. and Roberts, J. M. (1999). CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501-1512.
51. Slingerland, J. and Pagano, M. (2000). Regulation of the cdk inhibitor p27 and its deregulation in cancer. J. Cell Physiol. 183, 10-17.
52. Song, C., Hu, C. D., Masago, M., Kariyai, K., Yamawaki-Kataoka, Y., Shibatohge, M., Wu, D., Satoh, T. and Kataoka, T. (2001). Regulation of a novel human phospholipase C, PLCepsilon, through membrane targeting by Ras. J. Biol. Chem. 276, 2752-2757.
53. Stacey, D. W., Roudebush, M., Day, R., Mosser, S. D., Gibbs, J. B. and Feig, L. A. (1991). Dominant inhibitory Ras mutants demonstrate the requirement for Ras activity in the action of tyrosine kinase oncogenes. Oncogene 6, 2297-2304.
54. Takuwa, N. and Takuwa, Y. (1997). Ras activity late in G1 phase required for p27kip1 downregulation, passage through the restriction point, and entry into S phase in growth factor-stimulated NIH 3T3 fibroblasts. Mol. Cell. Biol. 17, 5348-5358.
55. Weber, J. D., Raben, D. M., Phillips, P. J. and Baldassare, J. J. (1997). Sustained activation of extracellular-signal-regulated kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phase. Biochem. J. 326, 61-68.
56. Weinberg, R. A. (1995). The retinoblastoma protein and cell cycle control. Cell 81, 323-330.
57. Winston, J. T., Coats, S. R., Wang, Y. Z. and Pledger, W. J. (1996). Regulation of the cell cycle machinery by oncogenic ras. Oncogene 12, 127-134.
58. Zarkowska, T. and Mittnacht, S. (1997). Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases. J. Biol. Chem. 272, 12738-12746.